Guanoxabenz

Guanoxabenz

SCHEMBL7199677

N=C(N)NO.N=C(NO)N/N=C/c1c(Cl)cccc1Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ SLC22A1 O15245 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ADRA2C P18825 1/20 0.45
▸ MAOA P21397 1/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ TBXA2R P21731 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ ADRA1D P25100 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ HTR2B P41595 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanoxabenz SCHEMBL122726 0.94 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A
Guanoxabenz SCHEMBL10409620 0.94 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL4103258 0.85 POLB (0.57) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL15389 0.85 POLB (0.57) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL6302549 0.85 POLB (0.57) POLBHTTSLC22A1HTR1AADRA2A
SCHEMBL19449739 0.85 POLB (0.60) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL11685908 0.84 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL170112 0.84 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL22616212 0.84 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A
Guanabenz SCHEMBL22616213 0.84 POLB (0.55) POLBHTTSLC22A1HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599943-B1 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase WAPHARM AB (SE) 2003-07-29 — — US disclosed
EP-1007025-A1 USE OF HYDROXYGUANIDINES Wa Pharm AB (SE) 2000-06-14 — — EP disclosed
WO-1998023267-A1 USE OF HYDROXYGUANIDINES WAPHARM AB (SE) 1998-06-04 — — WO disclosed
Send feedback